Prevention of spontaneous tumours in female rats by fadrozole hydrochloride, an aromatase inhibitor (Q36081916)

12 August 2017

Prevention of spontaneous tumours in female rats by fadrozole hydrochloride, an aromatase inhibitor (English)

1 reference

12 August 2017

Gunson DE

1

1 reference

12 August 2017

Steele RE

series ordinal

2

1 reference

12 August 2017

Chau RY

series ordinal

3

1 reference

12 August 2017

language of work or name

English

0 references

publication date

1 July 1995

1 reference

British Journal of Cancer

12 August 2017

1 reference

12 August 2017

72

1 reference

12 August 2017

1

1 reference

12 August 2017

72-75

1 reference

https://scigraph.springernature.com/pub.10.1038/bjc.1995.279

12 August 2017

0 references

cites work

Recent developments in aromatase inhibition as a potential treatment for oestrogen-dependent breast cancer.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2034132

Development of antiestrogens and their use in breast cancer: eighth Cain memorial award lecture

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2034132

Novel aromatase inhibitors

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2034132

Scientific concepts, value, and significance of chemical carcinogenesis studies

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2034132

A study of fadrozole, a new aromatase inhibitor, in postmenopausal women with advanced metastatic breast cancer

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2034132

Neoplasms and related proliferative lesions in control Sprague-Dawley rats from carcinogenicity studies. Historical data and diagnostic considerations

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2034132

Antitumor and endocrine effects of an aromatase inhibitor (CGS 16949A) on DMBA-induced rat mammary tumor.

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2034132

The triphenylethylene drug tamoxifen is a strong liver carcinogen in the rat.

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2034132

Testing for a trend in tumor prevalence rates: I. Nonlethal tumors.

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2034132

In vitro and in vivo studies demonstrating potent and selective estrogen inhibition with the nonsteroidal aromatase inhibitor CGS 16949A.

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2034132

Inhibition of aromatase with CGS 16949A in postmenopausal women

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2034132

The effects of CGS 16949A, an aromatase inhibitor on adrenal mineralocorticoid biosynthesis.

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2034132

Oestrogen receptor and epidermal growth factor receptor expression in male breast carcinoma

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2034132

Changes in multiple or sequential estrogen receptor determinations in breast cancer

11 July 2018

1 reference

12 December 2020

Breast cancer in men. Clinical features, hormone receptor status, and response to therapy

1 reference

12 December 2020

CGS 16949A, a new nonsteroidal aromatase inhibitor: effects on hormone-dependent and -independent tumors in vivo

1 reference

12 December 2020

Suppression of mouse mammary tumorigenesis by long-term tamoxifen therapy

1 reference

12 December 2020

Antitumor effects of a nonsteroidal aromatase inhibitor (CGS 16949A) on 7, 12-dimethylbenz[alpha]anthracene-induced mammary tumors in rats

1 reference

12 December 2020

Identifiers

DOI

10.1038/BJC.1995.279

1 reference

12 August 2017

1 reference

12 August 2017

1 reference